CGEN

Compugen Ltd. · NASDAQ · Healthcare · USD · 20-F for 2025, filed 2026-03-02

Figures on this page computed 2026-11-08 12:32 UTC

Last close

1.96USD

Market data, 2026-11-06

CGEN: weekly closes from 2.41 on 2026-08-14 to 1.96 on 2026-11-06, a move of -18.7%. Prices in USD.

Weekly closes, 2026-08-14 to 2026-11-06

Over that span: -18.7%

Except where said otherwise: 20-F for 2025, filed 2026-03-02

5.3xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-02
The filing itself
207.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
48.6%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
43.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.46x

-1.65x

-2.30x

1.64x

0.47x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 20-F for 2025, filed 2026-03-02

Sales3.46x
Its own average over 8 years, 21.0M.
Profit-1.65x
Its own average over 10 years, -21.4M.
Free cash flow-2.30x
Its own average over 10 years, -13.6M.
Debt1.64x
Its own average over 4 years, 1.8M.
Price0.47x
Its own average over 11 years, 4. Market data, 2026-11-06

Free cash flow is furthest from its own average, at -2.30 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales
2016-12-31	100.0
2018-12-31	2,500.0
2020-12-31	280.9
2021-12-31	842.7
2022-12-31	1,053.4
2023-12-31	4,699.3
2024-12-31	3,913.5
2025-12-31	10,219.7

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001178913-26-000663
Reported in: USD

The filing itself

Figures behind the shape

Growth

105.2%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate105.2%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income348.4%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

207.2%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capital207.2%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Return on equity34.4%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Return on assets22.6%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself

Margins

87.3%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin87.3%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Operating margin43.0%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Net margin48.6%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Free cash flow margin43.0%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself

Price

5.3x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings5.3x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-02
The filing itself
Price to book1.8x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-02
The filing itself
EV to EBITDA3.1x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Price to sales ratio2.5x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- computed
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself

Safety

0.03

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equity0.03
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Current ratio6.56
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Interest coverage1118.8x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Altman Z-Score0.10
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 20-F for 2025, filed 2026-03-02
- Computed from the 20-F for 2025, filed 2026-03-02
- Computed from the 20-F for 2025, filed 2026-03-02
- Computed from the 20-F for 2025, filed 2026-03-02
- Computed from the 20-F for 2025, filed 2026-03-02

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001178913-26-000663
Reported in
USD
- 20-F for 2025, filed 2026-03-02
- Computed from the 20-F for 2025, filed 2026-03-02
- 20-F for 2025, filed 2026-03-02
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.